Alert Added Successfully

Endocrinology


               
Article Title Year Authour(s) Journal Subject Expert Rating Evidence Ranking
1. Increased Prevalence of Tricuspid Regurgitation in Patients with Prolactinomas Chronically Treated with Cabergoline 2008 Colao, A..., Galderisi, M..., Di Sarno, A... J Clin Endocrinol Metab Endocrinology B
2. Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study 2010 Nachtigall, L...B..., Valassi, E..., Lo, J... Clin Endocrinol Endocrinology B
3. Recurrence of Hyperprolactinemia following Withdrawal of Long-Term Cabergoline Therapy 2009 Mar 31 Kharlip, J..., Salvatori, R..., Yenokyan, G... J Clin Endocrinol Metab Endocrinology B
4. Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients 2009 Delgrange, E..., Daems, T..., Verhelst, J... Eur J Endocrinol Endocrinology B
5. Human Macroprolactin Displays Low Biological Activity via Its Homologous Receptor in a New Sensitive Bioassay 2006 Glezer, A., Soares, C.R.J., Vieira, J.G. J Clin Endocrinol Metab Endocrinology B
6. Acute Complications of Dopamine Agonist Treatment for Macroprolactinoma—How Uncommon? 2004 Nadesapillai, S., Balcere, I., Kaye, A.H. J Clin Neurosci Endocrinology B
7. Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systemic Review and Meta-Analysis 2010 Dekkers, O...M..., Lagro, J..., Burman, P... J Clin Endocrinol Metab Endocrinology A
8. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients 2006 Leaños-Miranda, A., Cárdenas-Mondragón, G., Rivera-Leaños, R. Clin Endocrinol (Oxf) Endocrinology B
9. Immunoglobulin G Subclasses and Prolactin (PRL) Isoforms in Macropro-lactinemia Due to Anti-PRL Autoantibodies 2005 Hattori, N., Ikekubo, K., Nakaya, Y. J Clin Endocrinol Metab Endocrinology B
10. Severe Multivalvular Heart Disease: A New Complication of the Ergot Derivative Dopamine Agonists 2004 Horvath, J., Fross, R.D., Kleiner-Fisman, G. Mov Disord Endocrinology C
11. Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas 2008 Jul 2 Vallette, S..., Serri, K..., Rivera, J... Pituitary Endocrinology B